Beth Hecht, See Remarks at Xeris Biopharma Holdings, Inc. (XERS), sold 40,000 shares at $5.43 ($217K) on 2025-03-20, disclosed to the SEC on 2025-03-21.
Open-market sale of $217k XERS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| XERS | SELL | 2026-07-02 | $134K | — | Filing → |
| XERS | SELL | 2026-06-02 | $101K | — | Filing → |
| XERS | SELL | 2026-05-01 | $104K | — | Filing → |